Monitoring ankylosing spondylitis: clinically useful markers and prediction of clinical outcomes

被引：12

作者：

Braun, Juergen ^{[1
]}

Kiltz, Uta ^{[1
]}

Sarholz, Michael ^{[1
]}

Heldmann, Frank ^{[1
]}

Regel, Andrea ^{[1
]}

Baraliakos, Xenofon ^{[1
]}

机构：

[1] Rheumazentrum Ruhrgebiet, D-44649 Herne, Germany

来源：

EXPERT REVIEW OF CLINICAL IMMUNOLOGY | 2015年 / 11卷 / 08期

关键词：

ankylosing spondylitis; disease activity; imaging; mobility; monitoring; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SOCIETY CLASSIFICATION CRITERIA; DISEASE-ACTIVITY SCORE; RESONANCE-IMAGING EXAMINATIONS; EVIDENCE-BASED RECOMMENDATIONS; DIFFERENT TREATMENT RESPONSES; ALPHA-ANTAGONIST THERAPY; ANTI-TNF THERAPY; SPINAL MOBILITY; DOUBLE-BLIND;

D O I：

10.1586/1744666X.2015.1052795

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Patient assessment in axial spondyloarthritis (axSpA) is multidimensional, and monitoring of disease activity, function and radiographic progression is complex. There is no simple 'gold standard' for measuring disease activity in all individual patients, as disease activity in axSpA is the sum of many different aspects and a complexity that cannot be represented by a single variable. Limited spinal mobility is a cardinal sign of ankylosing spondylitis and loss of spinal mobility has been reported to be a prognostic factor and most often evaluated with the Bath Ankylosing Spondylitis Functional Index. Imaging of the spine and assessment of safety aspects plays an important role in the monitoring of patients with axSpA. The timeframe for collecting information regarding disease activity, function and radiographic progression are recommended on an individual basis.

引用

页码：935 / 946

页数：12

共 114 条

[71] ASDAS, BASDAI and different treatment responses and their relation to biomarkers of infl ammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors [J].

Pedersen, Susanne Juhl ;

Sorensen, Inge Juul ;

Garnero, Patrick ;

Johansen, Julia Sidenius ;

Madsen, Ole Rintek ;

Tvede, Niels ;

Hansen, Michael Sejer ;

Thamsborg, Gorm ;

Andersen, Lis Smedegaard ;

Majgaard, Ole ;

Loft, Anne Gitte ;

Erlendsson, Jon ;

Asmussen, Karsten ;

Jurik, Anne Grethe ;

Moller, Jakob ;

Hasselquist, Maria ;

Mikkelsen, Dorrit ;

Skjodt, Thomas ;

Lambert, Robert ;

Hansen, Annette ;

Ostergaard, Mikkel .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (08) :1375-1381

[72] Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNFα inhibitors [J].

Pedersen, Susanne Juhl ;

Hetland, Merete Lund ;

Sorensen, Inge Juul ;

Ostergaard, Mikkel ;

Nielsen, Hans Jorgen ;

Johansen, Julia Sidenius .

CLINICAL RHEUMATOLOGY, 2010, 29 (11) :1301-1309

[73] Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor α inhibitors [J].

Pedersen, Susanne Juhl ;

Sorensen, Inge Juul ;

Hermann, Kay-Geert A. ;

Madsen, Ole Rintek ;

Tvede, Niels ;

Hansen, Michael Sejer ;

Thamsborg, Gorm ;

Andersen, Lis Smedegaard ;

Majgaard, Ole ;

Loft, Anne Gitte ;

Erlendsson, Jon ;

Asmussen, Karsten ;

Johansen, Julia S. ;

Jurik, Anne Grethe ;

Moller, Jakob ;

Hasselquist, Maria ;

Mikkelsen, Dorrit ;

Skjodt, Thomas ;

Hansen, Annette ;

Ostergaard, Mikkel .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (06) :1065-1071

[74] Longitudinal Numbers-Needed-To-Treat (NNT) for Achieving Various Levels of Analgesic Response and Improvement with Etoricoxib, Naproxen, and Placebo in Ankylosing Spondylitis [J].

Peloso, Paul M. ;

Gammaitoni, Arnold ;

Smugar, Steven S. ;

Wang, Hongwei ;

Moore, Andrew R. .

BMC MUSCULOSKELETAL DISORDERS, 2011, 12

[75]

Ramiro S, 2014, ANN RHEUM DIS, V74, P1218

[76] Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort [J].

Ramiro, Sofia ;

van der Heijde, Desiree ;

van Tubergen, Astrid ;

Stolwijk, Carmen ;

Dougados, Maxime ;

van den Bosch, Filip ;

Landewe, Robert .

ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (08) :1455-1461

[77] Immunogenicity of Monoclonal Antibodies Against Tumor Necrosis Factor Used in Chronic Immune-Mediated Inflammatory Conditions Systematic Review and Meta-analysis [J].

Ramon Maneiro, Jose ;

Salgado, Eva ;

Jesus Gomez-Reino, Juan .

JAMA INTERNAL MEDICINE, 2013, 173 (15) :1416-1428

[78] Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management [J].

Rossi, Roberta Elisa ;

Parisi, Ioanna ;

Despott, Edward John ;

Burroughs, Andrew Kenneth ;

O'Beirne, James ;

Conte, Dario ;

Hamilton, Mark Ian ;

Murray, Charles Daniel .

WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (46) :17352-17359

[79] The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general [J].

Rudwaleit, M. ;

van der Heijde, D. ;

Landewe, R. ;

Akkoc, N. ;

Brandt, J. ;

Chou, C. T. ;

Dougados, M. ;

Huang, F. ;

Gu, J. ;

Kirazli, Y. ;

Van den Bosch, F. ;

Olivieri, I. ;

Roussou, E. ;

Scarpato, S. ;

Sorensen, I. J. ;

Valle-Onate, R. ;

Weber, U. ;

Wei, J. ;

Sieper, J. .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (01) :25-31

[80] The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal [J].

Rudwaleit, M. ;

Landewe, R. ;

van der Heijde, D. ;

Listing, J. ;

Brandt, J. ;

Braun, J. ;

Burgos-Vargas, R. ;

Collantes-Estevez, E. ;

Davis, J. ;

Dijkmans, B. ;

Dougados, M. ;

Emery, P. ;

van der Horst-Bruinsma, I. E. ;

Inman, R. ;

Khan, M. A. ;

Leirisalo-Repo, M. ;

van der Linden, S. ;

Maksymowych, W. P. ;

Mielants, H. ;

Olivieri, I. ;

Sturrock, R. ;

de Vlam, K. ;

Sieper, J. .

ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (06) :770-776

← 3 4 5 6 7 8 9 10 11 12 →